Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis
Nutrients · 23.03.2024 · 16 (7) · 934
DOI: 10.3390/nu16070934 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrients, online erschienen am 23.03.2024. Verfasst von Preetha Iyengar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Randomized Controlled Trials as Topic, Phytotherapy. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Herbal medicines are used by patients with IBD despite limited evidence. We present a systematic review and meta-analysis of randomized controlled trials (RCTs) investigating treatment with herbal medicines in active ulcerative colitis (UC). A search query designed by a library informationist was used to identify potential articles for inclusion. Articles were screened and data were extracted by at least two investigators. Outcomes of interest included clinical response, clinical remission, endoscopic response, endoscopic remission, and safety. We identified 28 RCTs for 18 herbs. In pooled analyses, when compared with placebo, clinical response rates were significantly higher for Indigo naturalis (IN) (RR 3.70, 95% CI 1.97–6.95), but not for Curcuma longa (CL) (RR 1.60, 95% CI 0.99–2.58) or Andrographis paniculata (AP) (RR 0.95, 95% CI 0.71–1.26). There was a significantly higher rate of clinical remission for CL (RR 2.58, 95% CI 1.18–5.63), but not for AP (RR 1.31, 95% CI 0.86–2.01). Higher rates of endoscopic response (RR 1.56, 95% CI 1.08–2.26) and remission (RR 19.37, 95% CI 2.71–138.42) were significant for CL. CL has evidence supporting its use as an adjuvant therapy in active UC. Research with larger scale and well-designed RCTs, manufacturing regulations, and education are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA 90095, USA.
- Department of Medicine, University of Miami, Miami, FL 33136, USA.
- Center for Inflammatory Bowel Diseases, Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA 90095, USA.
- Welch Library, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
- Division of Gastroenterology and Hepatology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
ORCID-Profile: Preetha Iyengar, Gala Godoy-Brewer, Jacob White, Alyssa M Parian, Berkeley Limketkai
Zitieren
APA
Iyengar, P., Godoy-Brewer, G., Maniyar, I., White, J., Maas, L., Parian, A. M., & Limketkai, B. (2024). Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients, 16(7), 934. https://doi.org/10.3390/nu16070934
Vancouver
Iyengar P, Godoy-Brewer G, Maniyar I, White J, Maas L, Parian AM, et al. Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis. Nutrients. 2024;16(7):934. doi:10.3390/nu16070934
BibTeX
@article{Iyengar2024,
author = {Iyengar, Preetha and Godoy-Brewer, Gala and Maniyar, Isha and White, Jacob and Maas, Laura and Parian, Alyssa M and Limketkai, Berkeley},
title = {Herbal Medicines for the Treatment of Active Ulcerative Colitis: A Systematic Review and Meta-Analysis},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {7},
pages = {934},
doi = {10.3390/nu16070934}
}
EUVIMED